Kidney Stone Retrieval Devices Market Size, Trends, Share, Growth | Report 2022-2030
The global kidney stone retrieval devices market was surpassed at USD 2.7 billion in 2021 and is expected to hit around USD 3.82 billion by 2030, growing at a CAGR of 3.93% from 2022 to 2030.
Report Highlights
Kidney stone retrieval devices are used in minimally invasive or non-invasive treatment options for the removal of kidney stones. The rise in the incidence rate of kidney stones, technological advancements, and increased R&D investments are some of the factors fueling the growth of the global market.
Devices for retrieving kidney stones continue to advance incrementally. Considerably smaller ureter scopes, quartz fibers, and lithotripter probes have made the extraction of kidney stones from previously unreachable locations far safer than traditional surgical options. The potential for further apparatus miniaturization and optimization has expanded with the relatively recent advent of new technologies such as electromechanical and pneumatic impact lithotripsy. For instance, the Dretler stone cone is one innovation that inhibits stone migration during the treatment.
The COVID-19 pandemic affected the market due to the reduction in emergency room visits, increased number of patients with acute renal injury, and significantly delayed outpatient clinic appointments. These changes resulted in a significant backlog in treatments due to a lack of hospital beds, anesthesia or procedural slots, and healthcare personnel. As a result, the market was negatively impacted as the number of patients seeking diagnosis and treatments dropped drastically. The demand for kidney stone retrieval devices was uneven, with installation delays and a decline in manufacturing during the pandemic. The COVID-19 pandemic has also affected the world's supply chain network, and market players such as Boston Corporation and BD reported delays or interruptions in the shipments of several materials or components that go into manufacturing products.
The organizations are incorporating strategies such as alliances, acquisitions and partnerships, R&D investments, new product launches, and approvals to strengthen their competitive power while expanding their global reach. For instance, in June 2020, Olympus launched the Soltive SuperPulsed Laser System (Soltive Laser System), a novel application of thulium fiber laser technology intended for soft tissue and stone lithotripsy applications.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 2.7 billion |
| Revenue Forecast by 2030 | USD 3.82 billion |
| Growth rate from 2022 to 2030 | CAGR of 3.93% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Product type, treatment, end-use, region |
| Companies Covered | Boston Scientific Corporation; Olympus Corporation; BD; Cook; Coloplast Group; Dornier Medtech |
Product Type Insights
In 2021, the lithotripters segment dominated the market with a revenue share of over 30.04% owing to the increasing usage of these devices for treating kidney stones effectively. In addition, the low procedure costs and an increase in the utilization of shockwave lithotripsy procedures are the factors contributing to the segment growth. Third-generation lithotripters with cutting-edge technology are now being produced to increase the procedure's efficacy. Based on product type, the market is segmented into stone removal baskets, lithotripters, ureterorenoscopes, ureteral stents, and others.
The ureterorenoscopes segment is expected to register the fastest CAGR of 5.44% from 2022 to 2030. It has been gaining popularity among a number of healthcare organizations due to the decreased downtime caused by damaged equipment, which consequently reduces treatment delays and cancellations, improves access to care, and is even more cost-effective than its conventional counterparts. Furthermore, an increase in minimally invasive treatments and growth in healthcare spending boost the growth of the ureterorenoscopes segment.
Treatment Insights
In 2021, extracorporeal shock wave lithotripsy held the largest revenue share of over 40.04%, owing to an increase in the number of patients suffering from kidney stones, a recurrence rate of kidney stones, and the adoption of minimally invasive treatments. The treatment is minimally invasive, typically well tolerated, and rarely necessitates the use of a stent, thus fueling the segment growth. The surgery lasts around an hour, after which the patient can leave. Shockwave lithotripsy has a short recovery period and the patient can resume normal activities in a few days. The less invasive ESWL procedure is frequently chosen because there are normally no scopes put into the urinary tract and no stents are implanted. Based on treatment, the market is segmented into extracorporeal shock wave lithotripsy, percutaneous nephrolithotripsy, and intracorporeal ureteroscopy.
The intracorporeal ureteroscopy segment is expected to exhibit the fastest CAGR of 5.12% during the forecast period. It is typically preferred due to its advantages in stone-free rates and the fineness it frequently offers. Ureteroscopy, which uses a more direct approach and is subsequently more effective than ESWL, provides the benefit of only requiring a small number of stone particles to be removed following the treatment.
End-use Insights
The hospitals and clinics segment held the largest revenue share of over 50.08% in 2021 and is expected to retain its position during the forecast period. The necessary equipment required for kidney stone removal treatment is easily available in hospitals as compared to clinics and ambulatory surgical centers. Based on end-use, the market is segmented into hospitals and clinics, ambulatory surgery centers (ASCs), and specialty clinics.
The ambulatory surgery centers segment is likely to register a significant CAGR of 5.2% during the forecast period. These outpatient surgery centers are health care facilities where surgical procedures that do not require hospitalization are carried out. The majority of minor kidney stone operations can be completed in one day of surgery. The most preferred treatments, including shockwave lithotripsy, which are less complicated and do not require hospitalization, are carried out at ambulatory surgery centers.
Regional Insights
North America dominated the market and held a revenue share of over 40.04% in 2021. The increasing prevalence of kidney stone cases, the adoption of minimally invasive techniques, increased competition among market players, and significant expenditure on research and development to produce advanced technologies are contributing to the market growth in North America. There has been a steady growth in the number of patients with kidney stones from various states in the U.S. and Canada, thereby fueling the demand for kidney stone retrieval devices.
Asia Pacific is expected to expand at the fastest growth rate of 5.8% during the forecast period due to the rising frequency of kidney stones, rapidly expanding healthcare infrastructure, growing government backing, and an increasing number of startups in this region. In September 2021, Boston Scientific Corporation acquired Lumenis Ltd. for an upfront cash payment of USD 1.07 billion. It acquired Lumenis Ltd.’s global surgical business, which is into the development of energy-based medical solutions. This acquisition will allow Boston Scientific to use different medical solutions offered by Lumenis Ltd., including MOSES technology, which will help them expand throughout the Asia Pacific.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Kidney Stone Retrieval Devices Market
5.1. COVID-19 Landscape: Kidney Stone Retrieval Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Kidney Stone Retrieval Devices Market, By Product Type
8.1. Kidney Stone Retrieval Devices Market, by Product Type, 2022-2030
8.1.1 Lithotripters
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Stone Removal Baskets
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Ureterorenoscopes
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Ureteral Stents
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Kidney Stone Retrieval Devices Market, By Treatment
9.1. Kidney Stone Retrieval Devices Market, by Treatment, 2022-2030
9.1.1. Extracorporeal Shock Wave Lithotripsy
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Percutaneous Nephrolithotripsy
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Intracorporeal Ureteroscopy
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Kidney Stone Retrieval Devices Market, By End-use
10.1. Kidney Stone Retrieval Devices Market, by End-use, 2022-2030
10.1.1. Hospitals & Clinics
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Ambulatory Surgery Centers
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Specialty Clinics
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Kidney Stone Retrieval Devices Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product Type (2017-2030)
11.1.2. Market Revenue and Forecast, by Treatment (2017-2030)
11.1.3. Market Revenue and Forecast, by End-use (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product Type (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Treatment (2017-2030)
11.1.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product Type (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Treatment (2017-2030)
11.1.5.3. Market Revenue and Forecast, by End-use (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product Type (2017-2030)
11.2.2. Market Revenue and Forecast, by Treatment (2017-2030)
11.2.3. Market Revenue and Forecast, by End-use (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product Type (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Treatment (2017-2030)
11.2.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product Type (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Treatment (2017-2030)
11.2.5.3. Market Revenue and Forecast, by End-use (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product Type (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Treatment (2017-2030)
11.2.6.3. Market Revenue and Forecast, by End-use (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product Type (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Treatment (2017-2030)
11.2.7.3. Market Revenue and Forecast, by End-use (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product Type (2017-2030)
11.3.2. Market Revenue and Forecast, by Treatment (2017-2030)
11.3.3. Market Revenue and Forecast, by End-use (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product Type (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Treatment (2017-2030)
11.3.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product Type (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Treatment (2017-2030)
11.3.5.3. Market Revenue and Forecast, by End-use (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product Type (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Treatment (2017-2030)
11.3.6.3. Market Revenue and Forecast, by End-use (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product Type (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Treatment (2017-2030)
11.3.7.3. Market Revenue and Forecast, by End-use (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product Type (2017-2030)
11.4.2. Market Revenue and Forecast, by Treatment (2017-2030)
11.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product Type (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Treatment (2017-2030)
11.4.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product Type (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Treatment (2017-2030)
11.4.5.3. Market Revenue and Forecast, by End-use (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product Type (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Treatment (2017-2030)
11.4.6.3. Market Revenue and Forecast, by End-use (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product Type (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Treatment (2017-2030)
11.4.7.3. Market Revenue and Forecast, by End-use (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product Type (2017-2030)
11.5.2. Market Revenue and Forecast, by Treatment (2017-2030)
11.5.3. Market Revenue and Forecast, by End-use (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product Type (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Treatment (2017-2030)
11.5.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product Type (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Treatment (2017-2030)
11.5.5.3. Market Revenue and Forecast, by End-use (2017-2030)
Chapter 12. Company Profiles
12.1. Boston Scientific Corporation
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Olympus Corporation
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. BD
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Cook
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Coloplast Group
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Dornier Medtech
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers